Skip to main content

This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If your require further information, please visit Terms of use page.

X

Main navigation (without target group)

  • About Xiapex
    • About Xiapex
    • Mode of action
    • Effect
    • Safety
    • Administration & preparation
  • Dupuytren’s disease
    • Dupuytren’s disease
    • Prevalence
    • Impact
    • Causes
    • Current treatments
  • Xiapex training
  • FAQ
  • Links and material
  • Resources
    • Contact us
    • Register side effects
    • Full prescribing information

Are you a healthcare professional?

Yes
No
Sobi

© Swedish Orphan Biovitrum AB, 2016 | Xiapex ® | PP-3712
Cookies | Terms of use | Contact us | Full prescribing information
Last updated: 2018-04-20

Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm, Sweden | Phone: +46 8 697 20 00 | Reg.No. 556038-9321